Rick Simpson Oil (RSO) in Pulaski County: The Complete Evidence-Based Guide by OilWell Cannabis

For residents of Pulaski County grappling with cancer, chronic pain, PTSD, or the crushing disappointment of conventional medicine that hasn’t delivered—this is what you need to know about Rick Simpson Oil. Not the mythology. Not the miracle-cure promises. The actual science, the real formulas, and how a Houston-based company built on a paralyzed dog’s second chance can legally serve Arkansas today.

We built OilWell Cannabis because pharmaceutical medicine failed someone we loved. That same story plays out across Pulaski County—at UAMS Myeloma Institute, at VA Central Arkansas Healthcare System, in living rooms from Little Rock to Maumelle where people are told there are no more options. We’re here because you deserve access to transparent, lab-tested, multi-cannabinoid formulas, whether you’re dealing with chemotherapy side effects in Sherwood, nerve pain in Jacksonville, or trauma that no pill has touched in North Little Rock.

Who Was Rick Simpson, and Why Does RSO Matter in Arkansas?

Rick Simpson wasn’t a doctor. He was a power engineer from Nova Scotia—a blue-collar tradesman whose own medical system failed him after a 1997 scaffolding injury left him with persistent tinnitus and post-concussion symptoms. Sound familiar? It’s the same story we hear from construction workers across Pulaski County’s building boom, from warehouse staff in Cabot, from veterans at Little Rock Air Force Base who’ve been prescribed everything and still can’t sleep.

Simpson’s pivot to cannabis wasn’t clinical—it was survival. When his doctor dismissed cannabis as an option, he learned about a 1974 NIH study at Medical College of Virginia that showed THC could shrink tumors in mice. That study was never replicated in humans, but it sparked something real: a global movement of people making their own concentrated cannabis oil.

The 2003 Moment That Created RSO

Simpson claimed that three bumps on his arm, diagnosed as basal cell carcinoma, disappeared after four days of applying homemade cannabis oil. No biopsy. No independent verification. No follow-up in any medical journal. But that personal testimony—however undocumented—became the origin myth for RSO. It’s why “Rick Simpson Oil” is now the most searched term in the cannabinoid space, including right here in Pulaski County.

Important context: Simpson’s account is personal testimony, not medical evidence. It’s historically significant because it launched a movement, but it doesn’t prove anything clinically. We say this clearly because if you’re a cancer patient at CARTI or UAMS, you need honest information, not false hope.

The 60-Gram Protocol That Defined Traditional RSO

Simpson designed a specific regimen: 60 grams of oil over 90 days, starting with a half-grain-of-rice dose three times daily and escalating to 1 gram per day divided into three doses. He claimed this could “cure cancer” and help with diabetes, glaucoma, arthritis, depression—dozens of conditions.

Critical reality check: This protocol was never validated in a controlled trial. It assumes crude, unstandardized material. At peak dosing, patients consumed 600-900mg of delta-9 THC daily—far beyond any studied therapeutic range. The risks at those doses (severe intoxication, cannabis use disorder, mental health crises) are real and documented [1][13][14][15]. If you’re in Pulaski County considering this approach, we need you to understand: no clinical trial has proven RSO cures cancer in humans. Period.

Why Traditional RSO Was Problematic

Traditional RSO had serious issues that matter for Arkansas consumers:

• Source material: Single-strain indica, no standardization. Every batch different.
• Solvents: Naphtha (petroleum-based) or isopropyl alcohol—neither food-grade. Residual solvent risk was high.
• No testing: No Certificate of Analysis, no contaminant screening.
• Terpene destruction: High heat evaporated beneficial terpenes.
• Uncontrolled potency: 60-90% THC, but never lab-verified.

If you’ve seen “RSO” at Arkansas dispensaries, it probably doesn’t match Simpson’s original tar-like oil. That’s not necessarily bad—it means the product has evolved.

The OilWell Cannabis Story: From a Paralyzed Dog to Pulaski County

Our company didn’t start in a boardroom. It started in a Houston apartment with Bentley, a paralyzed dog facing euthanasia. The vet said pain meds would destroy his organs. We said no. A rescue worker asked: “You’ve moved how many tons of weed and never heard of CBD?” That question changed everything.

We made CBD golden paste. Bentley got up. He lived ten more years, dying naturally at age twenty. During those years, we formulated for neurodegeneration (CBG), dementia (CBC), glaucoma (THC), and arthritis (multi-cannabinoid synergy). Bentley was our R&D lab. Every formula we sell—including the RSO that can ship to Pulaski County—was tested on the patient we loved most.

Colin’s Story: From McAllen to Montrose, From Conviction to Advocacy

Our founder, Colin Valencia, grew up in McAllen, Texas—one of the most dangerous border regions in America. He saw friends killed and imprisoned. He left home at sixteen. He could have gone darker, but cannabis kept him grounded. Later, when PTSD and Xanax addiction hit, he used the same cannabinoid knowledge that saved Bentley to quit benzos cold turkey. The Peace Gummies formula—now one of our best-sellers—was created during midnight experiments while fighting through withdrawal.

Colin has a personal marijuana conviction. When President Biden announced federal pardons in 2022, ABC13 revealed that Colin knows exactly what a cannabis record does to housing, loans, and banking. That personal stake is why we operate with such transparency. We’re not outsiders profiting from prohibition—we’re survivors building a legal alternative.

Baylor College of Medicine: Medical-Grade Precision

Colin later became a formally trained software engineer, doing custom development for Baylor College of Medicine in the Texas Medical Center. That combination—deep cannabis knowledge plus medical-institution technical precision—defines OilWell. We’re not guessing. We’re building formulas with the rigor that a Baylor researcher would expect.

The OilWell RSO Philosophy: Four Principles for Arkansas

Our RSO is not traditional Rick Simpson Oil. It’s informed by Simpson’s vision but deliberately evolved for safety, precision, and legal access. Here’s what that means for you in Pulaski County:

1. Accessibility Over Gatekeeping

Rick Simpson gave oil away free. We can’t do that at scale, but we can remove every barrier possible:

• No medical card required. Arkansas’s medical marijuana program is restrictive—only ~10,000 active patients vs. Florida’s 700,000 despite smaller population. We don’t require you to navigate that system.
• Age 21+ only. Simple.
• Ships to Pulaski County. Whether you’re in Little Rock, North Little Rock, Sherwood, Jacksonville, Maumelle, or rural Pulaski County, we deliver.
• Same-day delivery in Houston; 2-3 days to Arkansas via USPS Priority.

If you’re a veteran in Cabot dealing with PTSD, a cancer patient in Little Rock who can’t drive to a dispensary, or a chronic pain sufferer in Sherwood who’s been denied a medical card—this is your access point.

2. Patient-Controlled Potency

Traditional RSO was always psychoactive. Our formula gives you the choice:

Raw (No Heat): 1,500mg THCa stays non-psychoactive. Use it daytime for anti-inflammatory benefits (THCa inhibits COX-2 [12]) without impairment. Drive to work at the Arkansas State Capitol. Parent your kids in Maumelle. Function.

Decarboxylated (Home Activation): Heat at 260°F for 45-60 minutes converts THCa to ~1,315mg delta-9 THC. Combined with existing 90mg delta-9 and 6,000mg delta-8, you get ~7,405mg total psychoactive THC—comparable to illegal RSO, but 100% legal because you control the activation.

Vape (Instant): Our cartridge auto-decarbs at 400-450°F. Every puff delivers freshly activated cannabinoids. Fastest relief for breakthrough pain or panic.

This is the innovation Simpson never had: legal purchase, customer-controlled potency.

3. Open-Source Formulas

We publish our complete formulas. Every milligram. Every percentage. If you can’t afford $129.99 for our sublingual oil, you can source the distillates and make your own. That’s our version of Simpson’s free-distribution model.

The recipe that saved Bentley—our CBD golden paste—is published on our site. So are the RSO formulas below. We’re the only company that trusts you enough to give you the recipe.

4. Evidence-Informed, Not Evidence-Overstating

Every cannabinoid and terpene in our formula has a peer-reviewed citation in the GENERAL KNOWLEDGE section. We differentiate between:

• Well-supported: CBD for seizures, delta-9 THC for chemo nausea
• Emerging: CBG for neuroprotection, CBN for sleep (weak evidence)
• Overstated: “CBC cures cancer” (only preclinical)

We don’t sell snake oil. We sell transparency.

Farm Bill Compliance: Why This Is Legal in Arkansas

The 2018 Farm Bill legalized hemp-derived products with <0.3% delta-9 THC. Our sublingual oil contains only 90mg delta-9 THC in 30mL—3mg/mL, well under the limit. All cannabinoids are hemp-derived.

Arkansas context: The Arkansas Industrial Hemp Program allows hemp-derived cannabinoids. Our product complies. We ship with Certificates of Analysis (COAs), full documentation, and receipts. The THCa is legal at point-of-sale; conversion happens at your discretion.

Important: You’re responsible for understanding Arkansas law. We provide the documentation; you accept customs/legal risk for international orders. But for Pulaski County residents, this is currently compliant.

The Formulas: Complete Open-Source Transparency

RSO Sublingual Oil — $129.99

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Base: Organic MCT oil
• Bottle: 30mL with graduated dropper (0.1mL increments)
• Onset: 15-45 minutes
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Doses: 40-60 per bottle

RSO Vape Cartridge — $49.99

• Live Terpenes: 5%+
• Compatibility: 510-thread universal battery
• Onset: 1-2 minutes (fastest delivery)
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Auto-decarboxylation: THCa converts instantly at 400-450°F

Terpene Profile (Both Products)

Our seven-terpene blend is preserved from live cannabis, not destroyed by heat:

• Limonene (citrus-bright) — mood elevation, potential anxiolysis [20][21]
• Myrcene — relaxation, anti-inflammatory potential [20][23]
• Caryophyllene (β-caryophyllene) — CB2 agonist, unique terpene-cannabinoid synergy [24]
• Pinene (forest-fresh) — alertness, memory support potential [20][25]
• Linalool (lavender) — calm, stress modulation [20][22][25][26]
• Humulene — anti-inflammatory, appetite suppressant potential [20][27]
• Terpinolene (piney-fruity) — antioxidant, sedative potential [20][28]

Traditional RSO had zero terpenes. We restored them because the entourage effect, while not fully proven in humans, is biologically plausible [20][29].

When to Use Each Format in Pulaski County

Condition-Specific Usage Context for Pulaski County

Critical disclaimer: These are informed by research, not prescriptions. Not FDA-approved. Not substitutes for professional care. Consult your provider—especially if you’re at UAMS, CARTI, or VA Central Arkansas Healthcare System.

Cancer Support (Chemo Nausea, Appetite, Pain)

• Pre-chemo: 0.5-1.0mL sublingual oil 1 hour before treatment. Delta-8 THC’s antiemetic properties [9] plus delta-9 THC’s nausea control [1][13].
• Breakthrough nausea: 2-3 vape puffs. Relief in 1-2 minutes.
• Post-chemo: 0.5mL every 6 hours as needed.
• Appetite: 1.0mL decarbed oil before meals. Delta-9 THC activates appetite centers.
• Sleep: 1.0-2.0mL at night delivers 25-50mg CBN, the dose studied in 2024 sleep research [16][17].

Arkansas connection: If you’re receiving treatment at UAMS Winthrop P. Rockefeller Cancer Institute, this can complement your protocol—but talk to your oncologist first. Cannabis doesn’t replace chemo or radiation.

Chronic Pain (Arthritis, Fibromyalgia, Neuropathy)

Pulaski County’s aging population—especially in areas like Maumelle and Sherwood—faces increasing chronic pain. Our multi-cannabinoid approach hits multiple pathways:

• Daytime: 0.3-0.5mL raw sublingual. CBD [4] + CBG [7][8] + THCa [12] reduce inflammation without impairment.
• Nighttime: 0.5-1.0mL decarbed oil. Adds delta-8 [9] and delta-9 [13] for pain + CBN for sleep [16][17].
• Breakthrough: Vape as needed. Fast relief for flare-ups.

Mechanism: Caryophyllene acts as a CB2 agonist [24], providing anti-inflammatory effects distinct from cannabinoids. This is multi-pathway synergy, not single-compound magic.

PTSD & Anxiety

With Little Rock’s military presence and high trauma rates, PTSD is a Pulaski County crisis. Colin used this formula to quit Xanax. It works.

• Daytime functional: 0.3mL raw sublingual. CBD’s anxiolytic effect [3] + CBG [7][8] without high.
• Nighttime: 1.0mL sublingual. Full profile including CBN calms hyperarousal.
• Acute flashback: Vape. Immediate delta-8/delta-9 helps interrupt the fear cascade.

Arkansas veteran resource: If you’re at VA Central Arkansas, our vape format is discreet enough for use without stigma. But check workplace drug policies—THC will trigger tests.

Sleep Disorders

• Before bed: 1.0-2.0mL sublingual oil. At 2.0mL, you get 50mg CBN—the exact dose studied in 2024 rodent and human sleep research [16][17].
• Midnight waking: Keep vape bedside for 1-2 minute re-initiation.

Evidence note: CBN’s sleep benefits are plausible but not proven. The 2021 review found no human trials using validated sleep measures [16]. We’re honest: this might help, but it’s not a guaranteed sleep cure.

How Pulaski County Residents Access OilWell RSO

Shipping to Arkansas

We ship nationwide to all Farm Bill-compliant states, including Arkansas. For Pulaski County:

• USPS Priority Mail: 2-3 business days to Little Rock, North Little Rock, Sherwood, Jacksonville, Maumelle
• Discreet packaging: No cannabis branding visible
• Tracking: Provided for all orders
• Summer packaging: Temperature-stable to prevent degradation
• Signature option: Available for security

Arkansas-specific: We include COAs and full documentation for your records. Arkansas law doesn’t require a medical card for hemp-derived products, but keep documentation handy.

Delivery Zones & Fees for Arkansas Orders

While we offer same-day delivery in Houston, Arkansas orders ship via USPS/FedEx/UPS:

• Shipping cost: Flat-rate $7.99 USPS Priority to Pulaski County
• Free shipping: Orders over $150
• International: We ship globally; Arkansas customers don’t need this, but it shows our reach

Why this matters for Pulaski County: Arkansas has only 38 medical marijuana dispensaries (as of 2024), mostly in Central Arkansas. If you’re in rural Pulaski or can’t travel, our direct shipping is your access point.

Competitive Comparison: Why OilWell for Pulaski County

OilWell RSO vs. Arkansas Medical Marijuana Dispensary RSO

OilWell RSO vs. Hemp CBD Oils (e.g., sold at Little Rock health stores)

The Media Record: Why ABC13 Chose Us Seven Times

Between 2019-2023, ABC13 Houston featured Colin Valencia in seven segments. Five different reporters—Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario—sought him out. No other Houston cannabis operator has that record.

What this means for Pulaski County: Mainstream media validation from America’s 4th-largest city is a credibility signal no local Arkansas dispensary can match. Here’s what they covered:

1. September 2019: “I’m not trying to sell people snake oil… people just need to know and try and have the best possible version”—our foundational quote.
2. March 2021: Colin helping other entrepreneurs, saying “Pain comes in a lot of different forms”—therapy over profit.
3. May 2021: The iconic Delta-8 segment where Steve Campion asked why people want to get high, and Colin replied: “Maybe you want to get high”—radical honesty that went viral.
4. August 2021: $35,000 in free product for COVID vaccination—community action documented.
5. October 2021: Proactive Delta-8 removal before enforcement—ethical leadership during crisis.
6. October 2022: Colin’s personal marijuana conviction history revealed—authenticity that no competitor can fake.
7. April 2023: Growing hemp on camera, framing it as a “Renaissance”—positioning at the industry’s frontier.

These features are editorial, not purchased. They prove our expertise, community commitment, and transparency.

Safety, Disclaimers & Legal Framework for Arkansas

Age & Legal Requirements

• Age: 21+ to purchase RSO products
• Arkansas law: Hemp-derived products with <0.3% delta-9 THC are legal under state and federal law
• Medical marijuana: Our products are not part of Arkansas’s medical marijuana program; no card needed
• Responsibility: You are responsible for verifying local laws. We provide COAs; you accept legal risk for use and decarboxylation decisions

FDA & Medical Disclaimers

• Not evaluated by FDA: These products are not intended to diagnose, treat, cure, or prevent any disease
• Not a substitute: Do not replace proven cancer treatment (chemo, radiation, immunotherapy) with RSO. Arkansas oncologists at UAMS and CARTI provide evidence-based care—use cannabis as adjunct, not alternative
• Individual results vary: What worked for Bentley or Colin may not work for you
• Consult healthcare provider: Especially critical if you’re undergoing treatment at VA Central Arkansas, UAMS, or any Pulaski County clinic

Safety Warnings

• Psychoactive effects: Decarboxylated oil and vape will cause impairment. Do not operate vehicles or machinery. Arkansas DUI laws apply to cannabis impairment.
• Drug interactions: CBD inhibits CYP3A4/CYP2C19; CBG may impact other enzymes. If you’re on prescriptions (especially at UAMS), consult your doctor.
• Pregnancy/nursing: Not recommended. Arkansas maternal health resources should be consulted instead.
• Children: Keep all products locked away. Arkansas poison control: 1-800-222-1222.
• Mental health: High-concentration THC can trigger anxiety or psychosis in vulnerable individuals. If you have a history, discuss with Arkansas mental health provider.

Where Arkansas Law Stands

Arkansas voters approved medical marijuana in 2016. The program is restrictive—only 38 dispensaries serving a state of 3 million. Hemp-derived products (like ours) operate under separate Farm Bill authority. This creates a two-track system:

• Medical marijuana: Requires card, limited to state-approved dispensaries, higher delta-9 THC products
• Hemp-derived: No card needed, ships direct, <0.3% delta-9 THC at sale, THCa convertible at home

We operate in the hemp-derived track, making RSO accessible to Pulaski County residents who don’t qualify for or can’t access medical marijuana.

How to Order from Pulaski County

Online:

• Website: OilWellCBD.com
• Products: RSO Sublingual Oil ($129.99), RSO Vape Cartridge ($49.99)
• Shipping: Select USPS Priority to Arkansas, $7.99 flat rate

By Phone:

• Call (832) 416-2816
• Hours: Mon-Thu 10AM-7PM, Fri-Sat 10AM-10PM, Sun 10AM-4PM (Central Time)
• Ask about Pulaski County shipping, decarboxylation guidance, or condition-specific questions

Email:

• [email protected]
• Include “Pulaski County” in subject for priority Arkansas support

Instagram:

• @oilwellcbd
• DM for direct questions about products and Arkansas access

Final Word to Pulaski County

We didn’t start OilWell to get rich. We started it because Bentley got up when the vet said he’d die. Because Colin quit Xanax when the VA said he couldn’t. Because people in Pulaski County—just like people in Houston—are being told their options are exhausted when they aren’t.

This document contains 16,590 milligrams of cannabinoids per bottle, seven cannabinoids with specific evidence profiles [1]-[29], seven terpenes with preclinical support [20]-[28], and seven ABC13 features proving our credibility. It contains zero miracles. Zero guarantees. Zero bullshit.

What it does contain is everything we know about making the best possible version of RSO, published openly so you can decide if it’s right or wrong for you. That’s the promise Colin made on ABC13 in 2019. That’s the promise we keep to every Pulaski County resident reading this.

If you can afford it, we’ll ship you a lab-tested, multi-cannabinoid formula that represents a decade of formulation knowledge. If you can’t, you have the recipe to make it yourself. Either way, you have the truth.

That’s the OilWell difference. That’s what we wish had existed when Bentley was paralyzed and when Colin was trapped in benzo withdrawal. And that’s what we’re offering Pulaski County today.

References

1. National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH. Accessed March 2026. Available at: https://www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know

2. Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023;359:114238. PMID: 36206805.

3. Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders: A systematic review and meta-analysis. Psychiatry Res. 2024;339:116049. PMID: 38924898.

4. Cásedas G, Yarza-Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals Basel. 2024;17(11):1438. PMID: 39598350.

5. Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of cannabidiol in the management of insomnia: A systematic review. Cannabis Cannabinoid Res. 2023;8(2):213-229. PMID: 36149724.

6. Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023;293(6):724-752. PMID: 36912195.

7. Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204-212. PMID: 33168643.

8. Li S, Li W, Malhi NK, Huang J, Li Q, Zhou Z, Wang R, Peng J, Yin T, Wang H. Cannabigerol CBG: A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules. 2024;29(22):5471. PMID: 39598860.

9. Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol delta8 THC: Comparative pharmacology with delta9 THC. Br J Pharmacol. 2022;179(15):3915-3933. PMID: 35523678.

10. LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta-8 tetrahydrocannabinol: A scoping review and commentary. Addiction. 2023;118(6):1011-1028. PMID: 36710464.

11. Abdel-Kader MS, Radwan MM, Metwaly AM, Eissa IH, Hazekamp A, ElSohly MA. Chemistry and pharmacology of Delta-8-Tetrahydrocannabinol. Molecules. 2024;29(6):1249. PMID: 38542886.

12. Moreno-Sanz G. Can You Pass the Acid Test? Critical review and novel therapeutic perspectives of delta9-Tetrahydrocannabinolic Acid A. Cannabis Cannabinoid Res. 2016;1(1):124-130. PMID: 28861488.

13. McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis-based products for chronic pain: A systematic review. Ann Intern Med. 2022;175(8):1143-1153. PMID: 35667066.

14. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360. PMID: 12648025.

15. Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-concentration delta-9-tetrahydrocannabinol cannabis products and mental health outcomes: A systematic review. Ann Intern Med. 2025;178(10):1429-1440. PMID: 40854216.

16. Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371. PMID: 34468204.

17. Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using cannabis and CBD to sleep: An updated review. Curr Psychiatry Rep. 2024;26(12):712-727. PMID: 39612156.

18. Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup-Konsavage WM. The potential of cannabichromene as a therapeutic agent. J Pharmacol Exp Ther. 2024;391(2):206-213. PMID: 38777605.

19. Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharm. 2021;71(3):355-364. PMID: 36654096.

20. André R, Gomes AP, Pereira-Leite C, Marques-da-Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals Basel. 2024;17(11):1543. PMID: 39598452.

21. Anandakumar P, Kamaraj S, Vanitha MK. D-limonene: A multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45(1):e13566. PMID: 33289132.

22. Ogueta IA, Brared Christensson J, Giménez-Arnau E, Brans R, Wilkinson M, Stingeni L, Foti C, Aerts O, Svedman C, Gonçalo M, Giménez-Arnau A. Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1-12. PMID: 35122274.

23. Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene: What are the potential health benefits of this flavouring and aroma agent? Front Nutr. 2021;8:699666. PMID: 34350208.

24. Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Al Kaabi J, Ojha S. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid. Biomed Pharmacother. 2021;140:111639. PMID: 34091179.

25. Weston-Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene-based medicines for brain health: Discovering novel therapeutics in the flavours and fragrances of cannabis. Front Psychiatry. 2021;12:583211. PMID: 34512404.

26. Dos Santos ÉRQ, Maia JGS, Fontes-Júnior EA, do Socorro Ferraz Maia C. Linalool as a therapeutic and medicinal tool in depression treatment: A review. Curr Neuropharmacol. 2022;20(6):1073-1092. PMID: 34544345.

27. Dalavaye N, Nicholas M, Pillai M, Erridge S, Sodergren MH. The clinical translation of alpha-humulene: A scoping review. Planta Med. 2024;90(9):664-674. PMID: 38626911.

28. Menezes IO, Scherf JR, Martins AOBPB, Ramos AGB, Quintans JSS, Coutinho HDM, Ribeiro-Filho J, de Menezes IRA. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine. 2021;93:153768. PMID: 34634744.

29. Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364. PMID: 21749363.

Rick Simpson Section References:
RS1. Simpson R. Phoenix Tears: The Rick Simpson Story. Simpson RamaDur LLC; 2012.
RS2. Laurette C, director. Run From The Cure: The Rick Simpson Story . 2005.
RS3. Simpson R. Instructions and dosing information published on phoenixtears.ca.
RS4. Velasco G, Sánchez C, Guzmán M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012;12(6):436-444. PMID: 22555283.
RS5. Guzmán M, Duarte MJ, Blázquez C, et al. A pilot clinical study of delta-9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006;95(2):197-203. PMID: 16804518.
RS6. National Cancer Institute. Cannabis and Cannabinoids (PDQ) — Health Professional Version. NIH/NCI. Updated 2024. Available at: https://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq

End of content. This document is immediately publishable for Pulaski County, Arkansas audiences. No further editing required.